Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.
Clinical
Treatment options for COVID-19: Dr. Annie Luetkemeyer
Clinical
-
Stroke is ‘not a common complication’ in COVID-19 -
Ten reasons airborne transmission of SARS-CoV-2 appears airtight -
-
-
Watch for abnormal movements in hospitalized COVID-19 patients -
-
-
-
Blacks and Hispanics have higher inpatient use for mycosis fungoides -
Quality
Practice Management
-
-
-
-
About one in five clinicians considers quitting because of pandemic -
-
-
-
-
-
From the Society
Video
-
Critical care and COVID-19: Dr. Matt Aldrich -
Treatment options for COVID-19: Dr. Annie Luetkemeyer -
Managing the COVID-19 isolation floor at UCSF Medical Center -
-
